Glomerular Complement Factor H–Related Protein 5 (FHR5) Is Highly Prevalent in C3 Glomerulopathy and Associated With Renal Impairment

Pickering, 2013, C3 glomerulopathy: consensus report, Kidney Int, 84, 1079, 10.1038/ki.2013.377

Goodship, 2017, Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference, Kidney Int, 91, 539, 10.1016/j.kint.2016.10.005

Ricklin, 2018, The renaissance of complement therapeutics, Nat Rev Nephrol, 14, 26, 10.1038/nrneph.2017.156

Servais, 2012, Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies, Kidney Int, 82, 454, 10.1038/ki.2012.63

Bomback, 2018, C3 glomerulonephritis and dense deposit disease share a similar disease course in a large United States cohort of patients with C3 glomerulopathy, Kidney Int, 93, 977, 10.1016/j.kint.2017.10.022

Fakhouri, 2010, C3 glomerulopathy: a new classification, Nat Rev Nephrol, 6, 494, 10.1038/nrneph.2010.85

Rodriguez de Cordoba, 2004, The human complement factor H: functional roles, genetic variations and disease associations, Mol Immunol, 41, 355, 10.1016/j.molimm.2004.02.005

Medjeral-Thomas, 2016, The complement factor H-related proteins, Immunol Rev, 274, 191, 10.1111/imr.12477

Gale, 2010, Identification of a mutation in complement factor H-related protein 5 in patients of Cypriot origin with glomerulonephritis, Lancet, 376, 794, 10.1016/S0140-6736(10)60670-8

Medjeral-Thomas, 2014, A novel CFHR5 fusion protein causes C3 glomerulopathy in a family without Cypriot ancestry, Kidney Int, 85, 933, 10.1038/ki.2013.348

Chen, 2014, Complement factor H-related hybrid protein deregulates complement in dense deposit disease, J Clin Invest, 124, 145, 10.1172/JCI71866

Togarsimalemath, 2017, A novel CFHR1-CFHR5 hybrid leads to a familial dominant C3 glomerulopathy, Kidney Int, 92, 876, 10.1016/j.kint.2017.04.025

Xiao, 2016, Familial C3 glomerulonephritis caused by a novel CFHR5-CFHR2 fusion gene, Mol Immunol, 77, 89, 10.1016/j.molimm.2016.07.007

Schulze, 1993, Glomerular C3c localization indicates ongoing immune deposit formation and complement activation in experimental glomerulonephritis, Am J Pathol, 142, 179

Murphy, 2002, Factor H-related protein-5: a novel component of human glomerular immune deposits, Am J Kidney Dis, 39, 24, 10.1053/ajkd.2002.29873

Goicoechea de Jorge, 2013, Dimerization of complement factor H-related proteins modulates complement activation in vivo, Proc Natl Acad Sci U S A, 110, 4685, 10.1073/pnas.1219260110

Vernon, 2011, Recurrence of complement factor H-related protein 5 nephropathy in a renal transplant, Am J Transplant, 11, 152, 10.1111/j.1600-6143.2010.03333.x

Tortajada, 2013, C3 glomerulopathy-associated CFHR1 mutation alters FHR oligomerization and complement regulation, J Clin Invest, 123, 2434, 10.1172/JCI68280

Csincsi, 2015, Factor H-related protein 5 interacts with pentraxin 3 and the extracellular matrix and modulates complement activation, J Immunol, 194, 4963, 10.4049/jimmunol.1403121

Zhu, 2018, Circulating complement factor H-related protein 5 levels contribute to development and progression of IgA nephropathy, Kidney Int, 94, 150, 10.1016/j.kint.2018.02.023

Medjeral-Thomas, 2017, Circulating complement factor H-related proteins 1 and 5 correlate with disease activity in IgA nephropathy, Kidney Int, 92, 942, 10.1016/j.kint.2017.03.043

Medjeral-Thomas, 2018, Progressive IgA nephropathy is associated with low circulating mannan-binding lectin-associated serine protease-3 (MASP-3) and increased glomerular factor H-related protein-5 (FHR5) deposition, Kidney Int Rep, 3, 426, 10.1016/j.ekir.2017.11.015

Levey, 2009, A new equation to estimate glomerular filtration rate, Ann Intern Med, 150, 604, 10.7326/0003-4819-150-9-200905050-00006

Schwartz, 2012, Improved equations estimating GFR in children with chronic kidney disease using an immunonephelometric determination of cystatin C, Kidney Int, 82, 445, 10.1038/ki.2012.169

Schindelin, 2012, Fiji: an open-source platform for biological-image analysis, Nat Methods, 9, 676, 10.1038/nmeth.2019

Benjamini, 2006, Adaptive linear step-up procedures that control the false discovery rate, Biometrika, 96, 491, 10.1093/biomet/93.3.491

West, 1995, Paramesangial glomerular deposits in membranoproliferative glomerulonephritis type II correlate with hypocomplementemia, Am J Kidney Dis, 25, 853, 10.1016/0272-6386(95)90567-7

Ogrodowski, 1991, Measurement of SC5b-9 in urine in patients with the nephrotic syndrome, Kidney Int, 40, 1141, 10.1038/ki.1991.326

Wilson, 2019, Glomerular membrane attack complex is not a reliable marker of ongoing C5 activation in lupus nephritis, Kidney Int, 95, 655, 10.1016/j.kint.2018.09.027

Pickering, 2006, Prevention of C5 activation ameliorates spontaneous and experimental glomerulonephritis in factor H-deficient mice, Proc Natl Acad Sci U S A, 103, 9649, 10.1073/pnas.0601094103

Morita, 1997, The role of complement in the pathogenesis of tubulointerstitial lesions in rat mesangial proliferative glomerulonephritis, J Am Soc Nephrol, 8, 1363, 10.1681/ASN.V891363

Sethi, 2017, Characterization of C3 in C3 glomerulopathy, Nephrol Dial Transplant, 32, 459

Rudnick, 2018, FHR5 binds to laminins, uses separate C3b and surface-binding sites, and activates complement on malondialdehyde-acetaldehyde surfaces, J Immunol, 200, 2280, 10.4049/jimmunol.1701641